NEWSLETTER
| LOGIN
| SIGNUP
Locate all Pharmaceutical resources, white papers, articles, blogs and videos here
NEWSLETTER
|
LOGIN
|
SIGNUP
News
Featured News
Trending News
Archive News
Events
All Events
Past Events
Upcoming Conferences
Past Conferences
Live Webinars
On-demand Webinars
Companies
Marketplace
C-Suite On Deck
Thought Leaders
Resources
Videos
Webinars
Articles
Infographics
Whitepapers
JavaScript has been disabled on your browser. The website might not work properly unless you enable it.
home.aspx
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
I agree to the
terms of service
and
privacy policy
.
.
https://pharmaceutical.report/Resources/Whitepapers/38f2a00b-ebc4-42fa-a101-cbba6bd257b4_TB-White-Paper-070918-ml.pdf
PLEASE CORRECT THE FOLLOWING:
Please Enter Some Keywords
Rapid and affordable antimicrobial resistance profiling of tuberculosis samples
whitepaper
SHARE
SHARE
SHARE
With over 10 million new cases worldwide each year and approximately 1.7 million deaths, tuberculosis (TB) is one of the leading global threats to human health. While disease detection and control methods have yielded a steady decline in the number of deaths attributable to TB, the emergence of multi-drug resistant (MDR) strains of Mycobacterium tuberculosis the predominant cause of TB is threatening to undermine this effort. Such strains are resistant to the most effective first-line drugs rifampicin and isoniazid and are associated with approximately 490,000 new cases of infection per annum1.
DOWNLOAD
I'm for real
Enter your email once to access all our information and resources.
(Your email address is required so we know you're a real person)
By downloading this content, you give permission for your contact information to be shared with the content provider who may contact you in regards to the content.